Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC
This study has been withdrawn prior to enrollment.
( Due to poor accrual of the study )
Study NCT00620971
Information provided by Hellenic Oncology Research Group
First Received on January 31, 2008.
Last Updated on April 8, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
